Search

everythinglearnresearchcommunity

for

Search:↓

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Mesenchymal stem cells help improve wound healing by reducing inflammation and promoting skin cell growth and movement.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Alcoholic extract of Eclipta alba may help treat allergies and is safe at high doses.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

A new one-step test can quickly identify skin cancer during surgery.

Topical glucocorticoids thin the skin and change collagen structure.

Dermal Wnt/β-catenin signaling is important for the proper size and development of hair follicles.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.